drugset / Trial / NCT01731067

Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot

NCT01731067

Phase 1 Completed 10 enrolled Jules Desmeules
Non-randomizedCrossoverOpen-labelDiagnostic

Summary

Phenotyping is an approach largely used for the evaluation of the activity of cytochromes and transporters in vivo. It consists of the administration of probe substances metabolised by a specific cytochrome or transported by P-glycoprotein (P-gp) for example, followed by the determination of a metabolic ratio or the evaluation of the plasmatic or urinary concentrations of the probe substances. The administration of a cocktail containing several probe substances allows the simultaneous evaluation of the activity of several cytochromes and P-gp in a single test. The aim of this project is the validation of a phenotyping cocktail of low dose probe drugs for the assessment of cytochrome P450 and P-gp activities by simple capillary blood sampling and dried blood spot (DBS) analysis. The cocktail consists of caffeine, bupropion, flurbiprofen, omeprazole, dextromethorphan, midazolam and fexofenadine for the simultaneous phenotyping of CYP1A2, CYP2B6, CYP2C9, CAP2C19, CYP2D6, CYP3A4 and P-gp, respectively. The modulation of the activity of cytochromes or P-gp will be evaluated by the administration of inhibitors (fluvoxamine, voriconazole, quinidine) or inducer (rifampicin) of the metabolic pathways or the P-gp mediated transport.

Timeline

Start
2012-11
Primary completion
2013-05
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 25 mg Oral
Subject Caffeine Small molecule Oral
Subject Dextromethorphan Unknown 5 mg Oral
Subject Fexofenadine Unknown 25 mg Oral
Subject Flurbiprofen Small molecule 25 mg Oral
Subject Midazolam Small molecule 1 mg Oral
Subject Omeprazole Other / unclassified 5 mg Oral

Indications

No indication recorded.